View Post

1 in 3 Women Don’t Have Enough Say in Their Breast Reconstruction Decision-Making

In In The News by Barbara Jacoby

Source: breastadvocateapp.com Patient’s relationships with their healthcare team can play a major role when it comes to planning medical procedures.  In the setting of breast cancer surgeons can greatly influence surgical decision-making. This is particularly the case when it comes to breast reconstruction. In the largest ever behavioral study focused on breast surgeons and breast cancer patients, results suggest surgeons play …

View Post

IZI Medical Products Announces the Launch of its fully automatic Quick-Core Auto Biopsy System

In In The News by Barbara Jacoby

Source: IZI Medical Products From: PR Newswire IZI Medical Products, LLC (“IZI”), a leading manufacturer of medical devices used in interventional radiology and interventional oncology procedures, announces the launch of its Quick-Core Auto Biopsy System (“Quick-Core Auto”) for soft tissue biopsy. The Quick-Core Auto is a lightweight, fully automatic biopsy device that builds upon the legacy of IZI’s Quick-Core semi-automatic …

View Post

Assessment of Screening Mammography Recommendations by Breast Cancer Centers in the US

In In The News by Barbara Jacoby

By: Erica Carbajal From: jamanetwork.com Most countries recommend that women receive breast cancer screening every 2 years between ages 50 and 69 years.1 In 2009 and 2016, the US Preventive Services Task Force (USPSTF) updated its recommendations to advise that women receive screening mammography every 2 years between ages 50 and 74 years, with the decision to begin screening earlier …

View Post

Do Oral Contraceptives Cause Cancer?

In In The News by Barbara Jacoby

From: healthline.com According to the Centers for Disease Control and Prevention (CDC)Trusted Source, roughly 14 percent of women ages 15 to 49 currently use the birth control pill. While hormonal birth control has benefits beyond pregnancy prevention, there are concerns that it may influence cancer risk. Research suggests that although oral contraceptives slightly increase the risk of breast and cervical …

View Post

Breast cancer: The risks of brominated flame retardants

In In The News by Barbara Jacoby

By: Institut national de la recherche scientifique – INRS From: medicalxpress.com Brominated flame retardants (BFRs) are found in furniture, electronics, and kitchenware to slow the spread of flames in the event of a fire. However, it has been shown that these molecules may lead to early mammary gland development, which is linked to an increased risk of breast cancer. The …

View Post

An Open Letter from the NATIONAL ADVOCACY ORGANIZATIONS ADDRESSING PUBLIC POLICY ISSUES IN CANCER

In In The News by Barbara Jacoby

CANCER LEADERSHIP COUNCIL A PATIENT-CENTERED FORUM OF NATIONAL ADVOCACY ORGANIZATIONS ADDRESSING PUBLIC POLICY ISSUES IN CANCER   The Honorable Xavier Becerra Secretary-Designate Department of Health and Human Services Hubert H. Humphrey Building 200 Independence Avenue SW Washington, DC 20201 Dear Secretary-Designate Becerra: The undersigned cancer patient, provider, and research organizations are writing to express opposition to certain new flexibilities that …

View Post

How Targeted Therapies Are Changing the Breast Cancer Treatment Landscape

In In The News by Barbara Jacoby

By: Jessica Skarzynski From: curetoday.com Targeted therapies that attack cancer in a more precise way than traditional chemotherapy are being used more in the field of breast cancer, but the solution in utilizing them lies within the patient-oncologist relationship, according to Dr. Dejan Juric. Juric, who is the director of the Termeer Center for Targeted Therapies at Massachusetts General Hospital …

View Post

‘Lost in Transition’ After Breast Cancer

In In The News by Barbara Jacoby

By: Colleen Moretti From: curetoday.com With more than 4 million breast cancer survivors in the U.S., survivorship care and understanding what happens to patients after surviving is of the utmost importance. An expert explains some side effects survivors may experience and treatments to help. The time after cancer treatment for survivors can sometimes be considered “lost in transition” since patients …

View Post

Escalation and De-escalation of Therapy Beneficial in HER2+ Breast Cancer

In In The News by Barbara Jacoby

By: Debu Tripathy, MD From: targetedonc.com Debu Tripathy, MD, discusses escalation and de-escalation of treatment in patients with HER2-positive breast cancer with HER2-targeted agents and chemotherapy. Debu Tripathy, MD, professor of medicine and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses escalation and de-escalation of treatment in patients with HER2-positive …

View Post

A new co-driver in breast cancer

In In The News by Barbara Jacoby

Source: University of Cincinnati From: eurekalert.org Cooperation is generally a good thing — working together to reach a goal. But in the case of cancer, it can be detrimental. University of Cincinnati researchers have discovered that cooperation between two key genes drive cancer growth, spread and treatment resistance in one particularly aggressive type of breast cancer. The good news is, …